All articles

NAD+ Injection Dosage and Frequency: What Studies Used

Reading time:

12 mins

Published on

Updated on

Longevity

Key Takeaways

  • NAD+ injections are compounded and not FDA-approved, so there is no official label or standard dose. Your own provider and the label on your vial set your dose and schedule.

  • Published human studies mostly tested IV NAD+ at 500 to 750 mg per session, in very small groups (2,4).

  • Units on an insulin syringe measure volume, not milligrams, so the same units can hold very different doses depending on your vial's concentration (5).

  • Faster IV delivery has been linked to more side effects, such as nausea, flushing and chest pressure (3). For more, see NAD+ injection side effects.

There is no standard NAD+ injection dosage and frequency. NAD+ injections are compounded, prescription-only products with no FDA approval, and the doses in published human research come mostly from small IV studies that used 500 to 750 mg per session (2,4). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality.

So what about all the dosage charts online? A chart is not a study. Below, you'll see what human research actually tested, how to read the label on your vial, and how to turn syringe units into milligrams yourself.

One rule runs through all of it. Concentration differs between pharmacies and vials, so always follow your own provider's instructions and the label on your vial. If your units don't match what you expected, ask your pharmacist or provider before you inject.

Key Takeaways

  • NAD+ injections are compounded and not FDA-approved, so there is no official label or standard dose. Your own provider and the label on your vial set your dose and schedule.

  • Published human studies mostly tested IV NAD+ at 500 to 750 mg per session, in very small groups (2,4).

  • Units on an insulin syringe measure volume, not milligrams, so the same units can hold very different doses depending on your vial's concentration (5).

  • Faster IV delivery has been linked to more side effects, such as nausea, flushing and chest pressure (3). For more, see NAD+ injection side effects.

There is no standard NAD+ injection dosage and frequency. NAD+ injections are compounded, prescription-only products with no FDA approval, and the doses in published human research come mostly from small IV studies that used 500 to 750 mg per session (2,4). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality.

So what about all the dosage charts online? A chart is not a study. Below, you'll see what human research actually tested, how to read the label on your vial, and how to turn syringe units into milligrams yourself.

One rule runs through all of it. Concentration differs between pharmacies and vials, so always follow your own provider's instructions and the label on your vial. If your units don't match what you expected, ask your pharmacist or provider before you inject.

No one has set a standard NAD+ injection dose

NAD+ (nicotinamide adenine dinucleotide) is a molecule your cells use to move energy from food toward fuel they can use (9). Injectable NAD+ is a compounded preparation, made by a pharmacy for an individual prescription, and FDA notes that compounded drugs do not go through its premarket approval process (1). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Without an approved product, there is no official label. So there is no approved dose and no approved schedule.

The research doesn't fill that gap yet. A 2026 review of IV NAD+ research described the human evidence as sparse, made up mostly of small uncontrolled studies, observational studies and case reports (3). The same review called the clinical evidence for effectiveness and long-term safety limited (3).

Keep that in mind when a website lists "the" daily dose. Check whether it points to a human study. Then check how many people were in it.

You can read more about what NAD+ does in your body in this NAD+ overview.

No one has set a standard NAD+ injection dose

NAD+ (nicotinamide adenine dinucleotide) is a molecule your cells use to move energy from food toward fuel they can use (9). Injectable NAD+ is a compounded preparation, made by a pharmacy for an individual prescription, and FDA notes that compounded drugs do not go through its premarket approval process (1). Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Without an approved product, there is no official label. So there is no approved dose and no approved schedule.

The research doesn't fill that gap yet. A 2026 review of IV NAD+ research described the human evidence as sparse, made up mostly of small uncontrolled studies, observational studies and case reports (3). The same review called the clinical evidence for effectiveness and long-term safety limited (3).

Keep that in mind when a website lists "the" daily dose. Check whether it points to a human study. Then check how many people were in it.

You can read more about what NAD+ does in your body in this NAD+ overview.

Published human studies tested IV doses of 500 to 750 mg

The best-documented injected NAD+ doses come from IV infusions, not shots. A 2019 pilot gave 750 mg over six hours, and a 2026 clinic-records study used 500 mg a day for four days (2,4). Both were small. Both focused on blood levels and tolerability, not long-term benefits.

Study

Who took part

Design

Route and dose

How often

What it measured

Grant et al., 2019 (2)

11 healthy men aged 30 to 55 (8 got NAD+, 3 got saline)

Pilot, saline control

IV NAD+, 750 mg at about 2 mg per minute

One 6-hour infusion

Blood and urine NAD+, adverse events

Reyna et al., 2026 (3,4)

Small clinic sample: 6 got NAD+, 8 got nicotinamide riboside (NR)

Retrospective records review, no placebo

IV NAD+ or IV NR, 500 mg

Daily for 4 days, 30-day follow-up

Tolerability, infusion time, lab markers

Martens et al., 2018 (8)

30 healthy middle-aged and older adults

Randomized, placebo-controlled crossover

Oral NR, 1,000 mg a day (a precursor, not NAD+)

Daily for 6 weeks

Tolerability, blood NAD+

In the 2019 pilot, blood NAD+ didn't budge for the first two hours. It rose by 398% only at the six-hour mark (2). The authors chose 750 mg empirically, to match a regimen commonly used in clinics (2).

The 2026 study drew on records from a commercial infusion setting rather than a controlled trial (4).

Published human studies tested IV doses of 500 to 750 mg

The best-documented injected NAD+ doses come from IV infusions, not shots. A 2019 pilot gave 750 mg over six hours, and a 2026 clinic-records study used 500 mg a day for four days (2,4). Both were small. Both focused on blood levels and tolerability, not long-term benefits.

Study

Who took part

Design

Route and dose

How often

What it measured

Grant et al., 2019 (2)

11 healthy men aged 30 to 55 (8 got NAD+, 3 got saline)

Pilot, saline control

IV NAD+, 750 mg at about 2 mg per minute

One 6-hour infusion

Blood and urine NAD+, adverse events

Reyna et al., 2026 (3,4)

Small clinic sample: 6 got NAD+, 8 got nicotinamide riboside (NR)

Retrospective records review, no placebo

IV NAD+ or IV NR, 500 mg

Daily for 4 days, 30-day follow-up

Tolerability, infusion time, lab markers

Martens et al., 2018 (8)

30 healthy middle-aged and older adults

Randomized, placebo-controlled crossover

Oral NR, 1,000 mg a day (a precursor, not NAD+)

Daily for 6 weeks

Tolerability, blood NAD+

In the 2019 pilot, blood NAD+ didn't budge for the first two hours. It rose by 398% only at the six-hour mark (2). The authors chose 750 mg empirically, to match a regimen commonly used in clinics (2).

The 2026 study drew on records from a commercial infusion setting rather than a controlled trial (4).

Subcutaneous and IM doses have almost no published data

If you're looking for an NAD+ subcutaneous injection dosage or an NAD+ intramuscular injection dosage, here's the plain answer. The published human studies covered in this guide all used IV infusions or oral precursors (2,4,8). Peer-reviewed human trials comparing subcutaneous or intramuscular NAD+ doses were not found in the research reviewed for this article.

A quick word on the routes:

  • Subcutaneous (SC or subQ): the medicine goes into the fatty tissue just under your skin, usually with a short, thin needle (6).

  • Intramuscular (IM): the medicine goes deeper, into a muscle such as your thigh or hip (7).

A dose dripped into a vein over hours can't simply be copied into a syringe. So any NAD+ dosage per day subcutaneous chart you find online is a protocol someone chose, not a result someone measured.

Technique still matters. For shots under the skin, MedlinePlus advises giving each injection at a different spot, at least an inch from the last one (6). For shots into muscle, it advises confirming your injection site with your provider first, because a poorly placed needle can hit a nerve or blood vessel (7). The NAD+ forms comparison covers how injections differ from nasal sprays and other forms.

Subcutaneous and IM doses have almost no published data

If you're looking for an NAD+ subcutaneous injection dosage or an NAD+ intramuscular injection dosage, here's the plain answer. The published human studies covered in this guide all used IV infusions or oral precursors (2,4,8). Peer-reviewed human trials comparing subcutaneous or intramuscular NAD+ doses were not found in the research reviewed for this article.

A quick word on the routes:

  • Subcutaneous (SC or subQ): the medicine goes into the fatty tissue just under your skin, usually with a short, thin needle (6).

  • Intramuscular (IM): the medicine goes deeper, into a muscle such as your thigh or hip (7).

A dose dripped into a vein over hours can't simply be copied into a syringe. So any NAD+ dosage per day subcutaneous chart you find online is a protocol someone chose, not a result someone measured.

Technique still matters. For shots under the skin, MedlinePlus advises giving each injection at a different spot, at least an inch from the last one (6). For shots into muscle, it advises confirming your injection site with your provider first, because a poorly placed needle can hit a nerve or blood vessel (7). The NAD+ forms comparison covers how injections differ from nasal sprays and other forms.

Your vial label holds the numbers that matter

Before any math, find three things on your vial label: the total amount of NAD+ in milligrams, the total liquid volume in milliliters, and the concentration in milligrams per milliliter (mg/mL). Concentration is the number that links syringe units to an actual dose.

Here's how to read your label, using made-up numbers for practice:

  1. Find the drug name and strength. It may read something like "NAD+ 500 mg/10 mL."

  2. Work out the concentration if it isn't printed. Divide total milligrams by total milliliters: 500 mg ÷ 10 mL = 50 mg/mL.

  3. Check that the label shows the right medicine, the right dose and an expiration or beyond-use date, as MedlinePlus advises for any injection (6).

  4. Read the storage instructions and follow them.

  5. Compare the label with your prescription instructions. If anything doesn't line up, call the pharmacy before you inject.

Those example numbers are only for learning the math. Concentration differs between pharmacies and vials, so your own label is the one that counts.

Three numbers turn syringe units into milligrams

A U-100 insulin syringe is marked for liquid that holds 100 units per mL, so 100 units on the barrel equals 1 mL (5). Each unit, then, is 0.01 mL. To find milligrams, divide your units by 100 to get mL, then multiply by your vial's concentration.

NAD+ isn't insulin. The "units" on the syringe are just a volume scale.

The formulas:

  • mL = units ÷ 100

  • mg = mL × concentration (mg/mL)

  • Going backward: mL = mg ÷ concentration, and units = mL × 100

Worked example (made-up numbers, not a dose recommendation): Say your label reads 500 mg/10 mL, which is 50 mg/mL. If your instructions say to draw 20 units, that's 0.2 mL. Multiply 0.2 mL by 50 mg/mL and you get 10 mg.

You can run these formulas on your phone as a simple NAD+ injection dosage calculator. One caution from insulin labeling applies here too: using a syringe not marked for U-100 can lead to a dosing mistake (5). Use the syringe your pharmacy or provider specifies.

An example chart shows why units alone mean nothing

The chart below uses three example concentrations to show what the same number of syringe units holds at each one. It is not a dosing chart. None of them is a recommended dose or any specific pharmacy's product.

EXAMPLE concentrations only. Follow your provider's instructions and your vial label.

Syringe units (U-100)

Volume (mL)

mg at 50 mg/mL

mg at 125 mg/mL

mg at 200 mg/mL

10 units

0.10 mL

5 mg

12.5 mg

20 mg

20 units

0.20 mL

10 mg

25 mg

40 mg

25 units

0.25 mL

12.5 mg

31.25 mg

50 mg

50 units

0.50 mL

25 mg

62.5 mg

100 mg

100 units

1.00 mL

50 mg

125 mg

200 mg

Read across a single row. Twenty units could mean 10 mg or 40 mg. Same syringe, four times the dose.

A generic NAD+ injection dosage chart can't tell you what to draw up for exactly this reason. Concentration differs between pharmacies and vials, so always follow your own provider's instructions and the label on your vial. If your units don't match what you expected, ask your pharmacist or provider.

A 500 mg vial tells you the total, not the dose

A "500 mg" vial tells you how much NAD+ the whole vial holds. It says nothing about how much goes into one injection. The same 500 mg can be mixed into different amounts of liquid, which changes the concentration and every number on your chart.

Here's what that looks like with example volumes:

Example vial

Concentration

What 20 units holds

500 mg in 2.5 mL

200 mg/mL

40 mg

500 mg in 4 mL

125 mg/mL

25 mg

500 mg in 10 mL

50 mg/mL

10 mg

So a "NAD+ 500 mg injection dosage chart" only makes sense once you know the liquid volume. Look for both numbers on your label. If the label shows only the total milligrams, ask the pharmacy for the concentration.

How often you inject is a provider decision, not a chart

Searching for an NAD+ injection dosage per week or an NAD+ dosage per week assumes there's a known schedule. So does searching for an NAD+ dosage per day. Research doesn't supply one. The human studies tested a single six-hour infusion or four daily infusions, and none compared daily shots with weekly shots (2,4).

Your provider weighs your health history, your other medications and how you respond. Your schedule may look nothing like a friend's, or like a chart online. That's expected.

A few practical habits help:

  • Write down each injection's date, units and site so you and your provider can spot patterns.

  • Keep your vial label handy when you message your provider about dosing.

  • Don't change your dose or how often you inject on your own. If your schedule feels off, ask your provider.

Curious whether NAD+ fits your goals? You can check your eligibility. An affiliated Mochi Medical provider decides whether it's appropriate and, if so, sets your dose and schedule.

Faster IV delivery has been tied to more side effects

Short-term effects reported during IV NAD+ include nausea, abdominal discomfort, flushing, cramping and chest pressure, particularly at faster infusion rates (3). In the 2026 clinic-records study, people getting NAD+ reported moderate to severe stomach symptoms, a faster heart rate and chest pressure during infusions (4).

Infusion speed may play a role. In the 2019 pilot, no adverse events were seen during a slow six-hour infusion at about 2 mg per minute (2). In the 2026 study, NAD+ infusions averaged about 97 minutes, compared with 37 minutes for NR (3).

In the 2026 study, standard liver and kidney blood markers did not change significantly in either group (4). Still, these were short studies in very few people, and long-term safety remains limited (3).

Shots carry their own, more local issues. MedlinePlus notes that some soreness after a shot under the skin is normal, but redness, swelling, red streaks or fever can signal infection and warrant a call to your provider (6). After a shot into muscle, a lump, bruise or swelling that doesn't go away is worth reporting too (7).

Oral NAD+ precursors use different milligram numbers

Many "NAD dosage per day" numbers online refer to pills, not injections. Most contain precursors, ingredients your body converts into NAD+. In one randomized crossover trial, 1,000 mg a day of oral nicotinamide riboside for six weeks was well tolerated and raised blood NAD+ in healthy middle-aged and older adults (8).

Don't swap numbers between forms. A milligram of a precursor pill and a milligram of injected NAD+ are different molecules taken by different routes. A study dose for one tells you nothing about the other.

Form

What it contains

Example dose from a published human study

IV infusion

NAD+

750 mg over 6 hours, once (2)

IV infusion

NAD+

500 mg daily for 4 days (4)

Oral capsule

Nicotinamide riboside (precursor)

1,000 mg a day for 6 weeks (8)

Subcutaneous or IM shot

NAD+

No peer-reviewed human dosing trial found

Some people need a closer look before NAD+

If you're pregnant, trying to get pregnant or breastfeeding, start there. The 2019 pilot enrolled only healthy men, and none of the injected NAD+ studies in this guide was designed to test NAD+ in pregnancy (2,4). So this research can't tell you whether it's safe for you.

Your provider also needs the full picture. Share every chronic condition you have, every medication and every supplement, including any NAD+ precursor pills. Long-term safety data are limited (3), so your history helps your provider weigh risks the studies couldn't measure.

Check your vial label for all listed ingredients, too. If you've ever reacted to an injection or a preservative, tell your provider before your first dose.

NAD+ through Mochi Health starts with a provider review

NAD+ injections are accessible through the Mochi platform as a compounded prescription. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. An affiliated Mochi Medical provider reviews your health history and, if NAD+ is appropriate, decides your dose and schedule.

Your pharmacy label is the final word on concentration. If the units in your instructions don't match what you'd expect from the label, ask before you inject.

NAD+ sits alongside other options on the Mochi longevity page, and you can browse the full medications list too.

The bottom line

No one has set a standard NAD+ injection dose or schedule. The best-documented doses, 500 to 750 mg per IV session, come from a handful of small studies, and shots under the skin or into muscle have almost no published dosing data (2,3,4). What you can control is the math. Read your vial's concentration, convert units to mL to mg, and follow your provider's instructions and your vial label every time. If you'd like a provider to review whether NAD+ makes sense for you, check your eligibility.

FAQs

How much NAD+ should I inject per day?

There's no established NAD+ injection dosage per day. Published human studies mostly tested IV NAD+ at 500 to 750 mg per session, in very small groups (2,4). Your provider sets your dose, and your vial label tells you how to measure it.

How many units of NAD+ should I inject?

It depends on your vial's concentration. On a U-100 syringe, 100 units equals 1 mL (5). Divide your units by 100, then multiply by the mg/mL on your label to get milligrams. Draw only the units your provider prescribes.

Is subcutaneous or intramuscular NAD+ better?

No peer-reviewed human trial comparing the two routes was found, and no published NAD+ subcutaneous injection dose or NAD+ IM injection dose comes from a human dosing trial. The published injected-NAD+ studies used IV infusions (2,4). Your provider chooses the route and can show you proper technique.

How long does an NAD+ IV infusion take?

In the 2019 pilot, 750 mg ran over six hours (2). In the 2026 clinic-records study, 500 mg NAD+ infusions averaged about 97 minutes (3). Faster rates have been linked to more side effects (3).

References

  1. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. Accessed November 2026.

  2. Grant R, Berg J, Mestayer R, et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience. 2019;11:257. doi:10.3389/fnagi.2019.00257. PMID: 31572171. PMCID: PMC6751327.

  3. Alangari A, Arif J, Al Qureshah F, Alkhodairy F. Narrative review of intravenous NAD+ and NAD+ precursors in wellness and translational medicine. Frontiers in Aging. 2026;7:1887175. doi:10.3389/fragi.2026.1887175. PMCID: PMC13601825.

  4. Reyna et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Frontiers in Aging. 2026;7:1652582. doi:10.3389/fragi.2026.1652582. PMID: 41704678. PMCID: PMC12907335.

  5. Eli Lilly and Company. Humulin R U-100 (insulin human injection) prescribing information. U.S. Food and Drug Administration (accessdata.fda.gov), label revision 2015, NDA 018780.

  6. MedlinePlus Medical Encyclopedia. Subcutaneous (SQ) injections. U.S. National Library of Medicine. medlineplus.gov/ency/patientinstructions/000430.htm. Accessed November 2026.

  7. MedlinePlus Medical Encyclopedia. Giving an IM (intramuscular) injection. U.S. National Library of Medicine. medlineplus.gov/ency/patientinstructions/000935.htm. Accessed November 2026.

  8. Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9:1286. doi:10.1038/s41467-018-03421-7. PMCID: PMC5876407.

  9. National Institutes of Health, Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Niacin-HealthProfessional/. Accessed November 2026.

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. NAD+ injections require a written prescription from a licensed provider. Speak with a provider to determine if NAD+ injections are appropriate for you. NAD+ injections are compounded preparations and are not FDA-approved for any use. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.